Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health


Personal tools

You are here: Home / Other Documents / Biomarkers At The Crossroads

Biomarkers At The Crossroads

NCI's Early Detection Research Network (EDRN) 5th Annual Scientific Workshop

NCI's Early Detection Research Network (EDRN) is a consortium of investigators committed to translational research on cancer biomarkers and advancing them to clinical application.  The main goals of the consortium are to enable population cancer screening, detection of cancers at an early stage, and ultimately reduction in morbidity and mortality.  Major efforts are devoted to developing and validating cancer biomarkers and to creating the necessary infrastructure for their clinical validation.  EDRN investigators are interested in novel approaches to identify new and improve existing biomarkers and developing assays to detect pre-malignant lesions. The workshop, entitled “Biomarkers at the Crossroads” is sponsored by EDRN to facilitate dissemination of new information and to highlight accomplishments in cancer biomarkers development.  The workshop will address various aspects of cancer biomarker development, including novel technologies that led to the identification of biomarkers, discoveries that hold the promise for early detection of cancer, and hurdles in translating basic science into clinical application.  Experts in diverse fields will discuss how such wealth of information can be applied to develop biomarkers for early detection of cancer. The tentative dates and the location are March 17-19, 2008 in Bethesda, MD.

2015 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place January 20–21, 2016 in Bethesda, Maryland.

Announcement 08/26/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held Wednesday-Thursday, January 20-21, 2016, on the NCI campus. More information will be available later this summer.

Announcement 06/30/2015

A funding opportunity for a new pancreatic cancer initiative, called The Pancreatic Cancer Detection Consortium (U01), has been released. For more information, please go to /grants/guide/ pa-files/ PAR-15-289.html.